Organization
Veracyte, Inc.
2 abstracts
Abstract
Biology and performance of pre- and post-pembrolizumab (Pembro) vesical imaging–reporting and data system (VI-RADS) to predict the pathological response in muscle-invasive urothelial bladder cancer (MIBC): Full data analysis from a clinical trials pipeline.Org: Vita-Salute San Raffaele University, IRCCS San Raffaele Milano, Veracyte, Inc., IRCCS Ospedale San Raffaele, Radiology Unit,
Abstract
Transcriptomic heterogeneity of metastatic disease timing within metastatic castration-sensitive prostate cancer.Org: Veracyte, Inc., Ghent University Hospital, Northwestern University Feinberg School of Medicine, Helen Diller Family Comprehensive Cancer Center, Oncology Institute of Southern Switzerland,